| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | TRIM72 FBXO40 TRIM25 TRIM58 C10orf90 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 TRIM50 RNF180 LNX1 UBE2E3 | 3.05e-10 | 473 | 147 | 20 | GO:0004842 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | TRIM72 FBXO40 TRIM25 TRIM58 C10orf90 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 TRIM50 RNF180 LNX1 UBE2E3 | 1.21e-09 | 512 | 147 | 20 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | TRIM72 FBXO40 TRIM25 TRIM58 C10orf90 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 TRIM50 RNF180 LNX1 UBE2E3 | 2.33e-09 | 532 | 147 | 20 | GO:0016755 |
| GeneOntologyMolecularFunction | acyltransferase activity | TRIM72 FBXO40 TRIM25 TRIM58 C10orf90 MBOAT4 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 NCOA1 RNF216 TRIM50 KAT6B RNF180 LNX1 UBE2E3 | 1.19e-08 | 775 | 147 | 23 | GO:0016746 |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | TRIM72 FBXO40 TRIM25 TRIM58 C10orf90 TRIM5 FBXO30 RNF220 UBE2D1 UBE2D2 UBE2D3 RNF10 RNF216 TRIM50 RNF180 | 1.09e-07 | 372 | 147 | 15 | GO:0061630 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | TRIM72 FBXO40 TRIM25 TRIM58 C10orf90 TRIM5 FBXO30 RNF220 UBE2D1 UBE2D2 UBE2D3 RNF10 RNF216 TRIM50 RNF180 | 2.59e-07 | 398 | 147 | 15 | GO:0061659 |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 2.77e-07 | 37 | 147 | 6 | GO:0061631 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 7.00e-07 | 43 | 147 | 6 | GO:0061650 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIM72 UBA5 FBXO40 TUT4 MID2 CYP2E1 TRIM58 MYO9B ZFAND2B AOC2 USP16 TRIM5 FBXO30 RNPEP MID1 CPXM1 RNF216 ALAD CYP4F12 TRIM50 ZSWIM4 CYP4F11 PPM1N PRIMPOL | 6.19e-06 | 1189 | 147 | 24 | GO:0046914 |
| GeneOntologyMolecularFunction | zinc ion binding | TRIM72 UBA5 FBXO40 TUT4 MID2 TRIM58 MYO9B ZFAND2B USP16 TRIM5 FBXO30 RNPEP MID1 CPXM1 RNF216 ALAD TRIM50 ZSWIM4 PRIMPOL | 3.03e-05 | 891 | 147 | 19 | GO:0008270 |
| GeneOntologyMolecularFunction | alpha-L-arabinofuranosidase activity | 5.38e-05 | 2 | 147 | 2 | GO:0046556 | |
| GeneOntologyMolecularFunction | dihydrosphingosine-1-phosphate phosphatase activity | 5.38e-05 | 2 | 147 | 2 | GO:0070780 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 5.31e-04 | 5 | 147 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 7.06e-04 | 24 | 147 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.00e-03 | 27 | 147 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.10e-03 | 7 | 147 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.10e-03 | 7 | 147 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate phosphatase activity | 1.10e-03 | 7 | 147 | 2 | GO:0042392 | |
| GeneOntologyBiologicalProcess | protein K48-linked ubiquitination | TRIM25 SKP2 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF216 UBE2E3 | 4.07e-08 | 100 | 147 | 9 | GO:0070936 |
| GeneOntologyBiologicalProcess | protein ubiquitination | TRIM72 TRIM25 MID2 TRIM58 C10orf90 SKP2 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 ASB16 RNF10 RNF216 TRIM50 RNF180 LNX1 UBE2E3 | 7.11e-08 | 811 | 147 | 22 | GO:0016567 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | TRIM72 UBA5 TRIM25 MID2 TRIM58 C10orf90 SKP2 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 ASB16 RNF10 RNF216 TRIM50 RNF180 LNX1 UBE2E3 | 8.85e-08 | 893 | 147 | 23 | GO:0032446 |
| GeneOntologyBiologicalProcess | protein polyubiquitination | TRIM25 TRIM58 C10orf90 SKP2 TRIM5 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF216 RNF180 UBE2E3 | 1.60e-07 | 289 | 147 | 13 | GO:0000209 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRIM72 UBA5 TRIM25 MID2 TRIM58 C10orf90 SKP2 USP16 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 ASB16 RNF10 RNF216 TRIM50 RNF180 LNX1 UBE2E3 | 1.95e-07 | 1009 | 147 | 24 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRIM72 UBA5 TRIM25 MID2 TRIM58 C10orf90 SKP2 USP16 TRIM5 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 ASB16 RNF10 RNF216 TRIM50 RNF180 LNX1 UBE2E3 | 6.03e-07 | 1074 | 147 | 24 | GO:0043687 |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | TRIM72 TUT4 TRIM25 TRIM58 ZFAND2B APC2 SKP2 CUL5 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 RNF180 LNX1 | 4.56e-06 | 656 | 147 | 17 | GO:0043632 |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | TRIM72 TRIM25 TRIM58 ZFAND2B APC2 SKP2 CUL5 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 RNF180 LNX1 | 1.38e-05 | 640 | 147 | 16 | GO:0006511 |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | TRIM72 TRIM25 TRIM58 ZFAND2B APC2 SKP2 CUL5 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 RNF180 LNX1 | 1.70e-05 | 651 | 147 | 16 | GO:0019941 |
| GeneOntologyBiologicalProcess | protein K63-linked ubiquitination | 1.72e-05 | 76 | 147 | 6 | GO:0070534 | |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 1.99e-05 | 78 | 147 | 6 | GO:0051865 | |
| GeneOntologyBiologicalProcess | negative regulation of viral entry into host cell | 4.44e-05 | 28 | 147 | 4 | GO:0046597 | |
| GeneOntologyBiologicalProcess | regulation of viral entry into host cell | 4.48e-05 | 55 | 147 | 5 | GO:0046596 | |
| GeneOntologyBiologicalProcess | arabinose metabolic process | 5.05e-05 | 2 | 147 | 2 | GO:0019566 | |
| GeneOntologyBiologicalProcess | vibrational conductance of sound to the inner ear | 5.05e-05 | 2 | 147 | 2 | GO:0055127 | |
| GeneOntologyBiologicalProcess | L-arabinose metabolic process | 5.05e-05 | 2 | 147 | 2 | GO:0046373 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | TRIM72 TRIM25 TRIM58 ZFAND2B APC2 SKP2 CUL5 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 ALAD RNF180 LNX1 | 6.92e-05 | 812 | 147 | 17 | GO:0051603 |
| GeneOntologyBiologicalProcess | modulation by symbiont of entry into host | 8.01e-05 | 62 | 147 | 5 | GO:0052372 | |
| GeneOntologyBiologicalProcess | negative regulation of viral life cycle | 8.63e-05 | 33 | 147 | 4 | GO:1903901 | |
| GeneOntologyBiologicalProcess | protein K29-linked ubiquitination | 9.63e-05 | 13 | 147 | 3 | GO:0035519 | |
| GeneOntologyBiologicalProcess | artery smooth muscle contraction | 9.63e-05 | 13 | 147 | 3 | GO:0014824 | |
| GeneOntologyBiologicalProcess | protein K27-linked ubiquitination | 1.22e-04 | 14 | 147 | 3 | GO:0044314 | |
| GeneOntologyBiologicalProcess | protein K11-linked ubiquitination | 1.36e-04 | 37 | 147 | 4 | GO:0070979 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 1.51e-04 | 3 | 147 | 2 | GO:0042361 | |
| GeneOntologyBiologicalProcess | tonic smooth muscle contraction | 1.52e-04 | 15 | 147 | 3 | GO:0014820 | |
| GeneOntologyBiologicalProcess | regulation of biological process involved in symbiotic interaction | 1.98e-04 | 75 | 147 | 5 | GO:0043903 | |
| GeneOntologyBiologicalProcess | protein K6-linked ubiquitination | 2.24e-04 | 17 | 147 | 3 | GO:0085020 | |
| GeneOntologyBiologicalProcess | suppression of viral release by host | 2.68e-04 | 18 | 147 | 3 | GO:0044790 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 3.00e-04 | 4 | 147 | 2 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 3.00e-04 | 4 | 147 | 2 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 3.00e-04 | 4 | 147 | 2 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 3.00e-04 | 4 | 147 | 2 | GO:0042377 | |
| GeneOntologyBiologicalProcess | protein catabolic process | TRIM72 TRIM25 TRIM58 ZFAND2B APC2 SKP2 TRIM5 CUL5 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNF10 RNF216 IRAK3 ALAD RNF180 LNX1 | 3.69e-04 | 1115 | 147 | 19 | GO:0030163 |
| GeneOntologyBiologicalProcess | sphingolipid catabolic process | 4.09e-04 | 49 | 147 | 4 | GO:0030149 | |
| GeneOntologyBiologicalProcess | protein monoubiquitination | 5.94e-04 | 54 | 147 | 4 | GO:0006513 | |
| GeneOntologyBiologicalProcess | membrane lipid catabolic process | 6.37e-04 | 55 | 147 | 4 | GO:0046466 | |
| GeneOntologyBiologicalProcess | regulation of Rab protein signal transduction | 7.43e-04 | 6 | 147 | 2 | GO:0032483 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 7.43e-04 | 6 | 147 | 2 | GO:0036101 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 7.43e-04 | 6 | 147 | 2 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 7.43e-04 | 6 | 147 | 2 | GO:0062232 | |
| GeneOntologyBiologicalProcess | proteasomal protein catabolic process | TRIM72 TRIM25 ZFAND2B APC2 SKP2 CUL5 UBE2D1 UBE2D3 RNF10 RNF216 ALAD RNF180 | 7.68e-04 | 567 | 147 | 12 | GO:0010498 |
| Domain | UBQ-conjugating_AS | 3.09e-08 | 25 | 145 | 6 | IPR023313 | |
| Domain | UQ_con | 5.21e-07 | 39 | 145 | 6 | PF00179 | |
| Domain | Znf_RING_CS | TRIM72 TRIM25 MID2 TRIM58 TRIM5 MID1 RNF10 TRIM50 RNF180 LNX1 | 5.83e-07 | 163 | 145 | 10 | IPR017907 |
| Domain | UBIQUITIN_CONJUGAT_1 | 6.09e-07 | 40 | 145 | 6 | PS00183 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 7.09e-07 | 41 | 145 | 6 | PS50127 | |
| Domain | UBQ-conjugat_E2 | 7.09e-07 | 41 | 145 | 6 | IPR000608 | |
| Domain | Butyrophylin | 1.17e-06 | 70 | 145 | 7 | IPR003879 | |
| Domain | - | 1.29e-06 | 71 | 145 | 7 | 4.10.45.10 | |
| Domain | - | 2.67e-06 | 51 | 145 | 6 | 3.10.110.10 | |
| Domain | ZF_RING_1 | TRIM72 TRIM25 MID2 TRIM58 TRIM5 RNF220 MID1 RNF10 RNF216 TRIM50 RNF180 LNX1 | 2.92e-06 | 291 | 145 | 12 | PS00518 |
| Domain | Znf_B-box | 3.16e-06 | 81 | 145 | 7 | IPR000315 | |
| Domain | UBQ-conjugating_enzyme/RWD | 3.36e-06 | 53 | 145 | 6 | IPR016135 | |
| Domain | ZF_RING_2 | TRIM72 TRIM25 MID2 TRIM58 TRIM5 RNF220 MID1 RNF10 RNF216 TRIM50 RNF180 LNX1 | 3.73e-06 | 298 | 145 | 12 | PS50089 |
| Domain | SPRY | 5.11e-06 | 87 | 145 | 7 | SM00449 | |
| Domain | zf-RING_UBOX | 6.11e-06 | 34 | 145 | 5 | PF13445 | |
| Domain | Znf-RING_LisH | 6.11e-06 | 34 | 145 | 5 | IPR027370 | |
| Domain | Znf_C3HC4_RING-type | 8.02e-06 | 172 | 145 | 9 | IPR018957 | |
| Domain | ConA-like_dom | TRIM72 FAT4 TRIM25 MID2 TRIM58 TRIM5 CELSR3 MID1 TRIM50 CRB2 | 8.32e-06 | 219 | 145 | 10 | IPR013320 |
| Domain | SPRY | 8.56e-06 | 94 | 145 | 7 | PF00622 | |
| Domain | SPRY_dom | 8.56e-06 | 94 | 145 | 7 | IPR003877 | |
| Domain | B30.2/SPRY | 9.19e-06 | 95 | 145 | 7 | IPR001870 | |
| Domain | B302_SPRY | 9.19e-06 | 95 | 145 | 7 | PS50188 | |
| Domain | zf-C3HC4 | TRIM72 TRIM25 MID2 TRIM58 TRIM5 MID1 RNF10 TRIM50 RNF180 LNX1 | 9.74e-06 | 223 | 145 | 10 | PF00097 |
| Domain | BBOX | 1.58e-05 | 69 | 145 | 6 | SM00336 | |
| Domain | PRY | 1.78e-05 | 42 | 145 | 5 | PF13765 | |
| Domain | zf-B_box | 2.02e-05 | 72 | 145 | 6 | PF00643 | |
| Domain | RING | TRIM72 TRIM25 MID2 TRIM58 TRIM5 RNF220 MID1 RNF10 TRIM50 RNF180 LNX1 | 2.67e-05 | 305 | 145 | 11 | SM00184 |
| Domain | PRY | 3.44e-05 | 48 | 145 | 5 | SM00589 | |
| Domain | PRY | 3.44e-05 | 48 | 145 | 5 | IPR006574 | |
| Domain | ZF_BBOX | 3.70e-05 | 80 | 145 | 6 | PS50119 | |
| Domain | - | TRIM72 TRIM25 MID2 TRIM58 USP16 TRIM5 RNF220 MID1 RNF10 TRIM50 KAT6B RNF180 LNX1 | 4.90e-05 | 449 | 145 | 13 | 3.30.40.10 |
| Domain | Znf_RING | TRIM72 TRIM25 MID2 TRIM58 TRIM5 RNF220 MID1 RNF10 TRIM50 RNF180 LNX1 | 4.90e-05 | 326 | 145 | 11 | IPR001841 |
| Domain | zf-TRAF_2 | 5.99e-05 | 2 | 145 | 2 | PF15965 | |
| Domain | F-box_4 | 5.99e-05 | 2 | 145 | 2 | PF15966 | |
| Domain | Fbxo30/Fbxo40 | 5.99e-05 | 2 | 145 | 2 | IPR031890 | |
| Domain | Znf_RING/FYVE/PHD | TRIM72 TRIM25 MID2 TRIM58 USP16 TRIM5 RNF220 MID1 RNF10 TRIM50 KAT6B RNF180 LNX1 | 6.13e-05 | 459 | 145 | 13 | IPR013083 |
| Domain | VWF_type-D | 2.38e-04 | 16 | 145 | 3 | IPR001846 | |
| Domain | VWFD | 2.38e-04 | 16 | 145 | 3 | PS51233 | |
| Domain | VWD | 2.38e-04 | 16 | 145 | 3 | SM00216 | |
| Domain | VWD | 2.38e-04 | 16 | 145 | 3 | PF00094 | |
| Domain | PPR | 3.56e-04 | 4 | 145 | 2 | PF01535 | |
| Domain | Rubredoxin-type_fold | 3.56e-04 | 4 | 145 | 2 | IPR004039 | |
| Domain | - | 3.56e-04 | 4 | 145 | 2 | 2.20.28.10 | |
| Domain | MCM_OB | 1.63e-03 | 8 | 145 | 2 | PF17207 | |
| Domain | MCM_OB | 1.63e-03 | 8 | 145 | 2 | IPR033762 | |
| Domain | PPR | 1.63e-03 | 8 | 145 | 2 | PS51375 | |
| Domain | MCM_2 | 1.63e-03 | 8 | 145 | 2 | PS50051 | |
| Domain | MCM_1 | 1.63e-03 | 8 | 145 | 2 | PS00847 | |
| Domain | MCM | 2.08e-03 | 9 | 145 | 2 | SM00350 | |
| Domain | MCM_dom | 2.08e-03 | 9 | 145 | 2 | IPR001208 | |
| Domain | MCM | 2.08e-03 | 9 | 145 | 2 | IPR031327 | |
| Domain | MCM | 2.08e-03 | 9 | 145 | 2 | PF00493 | |
| Domain | LAM_G_DOMAIN | 3.17e-03 | 38 | 145 | 3 | PS50025 | |
| Domain | EGF-like_dom | 3.35e-03 | 249 | 145 | 7 | IPR000742 | |
| Domain | Laminin_G_2 | 3.67e-03 | 40 | 145 | 3 | PF02210 | |
| Domain | COS | 3.75e-03 | 12 | 145 | 2 | PS51262 | |
| Domain | Znf_TRAF | 3.75e-03 | 12 | 145 | 2 | IPR001293 | |
| Domain | C8 | 3.75e-03 | 12 | 145 | 2 | PF08742 | |
| Domain | TIL | 3.75e-03 | 12 | 145 | 2 | PF01826 | |
| Domain | COS_domain | 3.75e-03 | 12 | 145 | 2 | IPR017903 | |
| Domain | ZF_TRAF | 4.41e-03 | 13 | 145 | 2 | PS50145 | |
| Domain | Unchr_dom_Cys-rich | 4.41e-03 | 13 | 145 | 2 | IPR014853 | |
| Domain | C8 | 4.41e-03 | 13 | 145 | 2 | SM00832 | |
| Domain | LamG | 4.81e-03 | 44 | 145 | 3 | SM00282 | |
| Domain | TIL_dom | 5.12e-03 | 14 | 145 | 2 | IPR002919 | |
| Domain | - | 5.12e-03 | 14 | 145 | 2 | 3.90.890.10 | |
| Domain | Cyt_P450_E_grp-I | 5.12e-03 | 45 | 145 | 3 | IPR002401 | |
| Domain | Bbox_C | 5.88e-03 | 15 | 145 | 2 | IPR003649 | |
| Domain | BBC | 5.88e-03 | 15 | 145 | 2 | SM00502 | |
| Domain | DENN | 6.69e-03 | 16 | 145 | 2 | SM00799 | |
| Domain | DENN | 6.69e-03 | 16 | 145 | 2 | PF02141 | |
| Domain | dDENN | 6.69e-03 | 16 | 145 | 2 | PF03455 | |
| Domain | SIAH-type | 6.69e-03 | 16 | 145 | 2 | IPR013323 | |
| Domain | UDENN | 6.69e-03 | 16 | 145 | 2 | PS50946 | |
| Domain | DDENN | 6.69e-03 | 16 | 145 | 2 | PS50947 | |
| Domain | dDENN | 6.69e-03 | 16 | 145 | 2 | SM00801 | |
| Domain | dDENN_dom | 6.69e-03 | 16 | 145 | 2 | IPR005112 | |
| Domain | uDENN_dom | 6.69e-03 | 16 | 145 | 2 | IPR005113 | |
| Domain | DENN | 6.69e-03 | 16 | 145 | 2 | PS50211 | |
| Domain | DENN_dom | 6.69e-03 | 16 | 145 | 2 | IPR001194 | |
| Domain | ASX_HYDROXYL | 7.69e-03 | 100 | 145 | 4 | PS00010 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | UBA5 FBXO40 SKP2 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 ASB16 TRIM50 LNX1 UBE2E3 | 7.28e-09 | 308 | 104 | 15 | M1070 |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | UBA5 FBXO40 SKP2 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 ASB16 TRIM50 LNX1 UBE2E3 | 1.22e-07 | 381 | 104 | 15 | M1066 |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | UBA5 FBXO40 SKP2 FBXO30 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 ASB16 TRIM50 LNX1 UBE2E3 | 2.95e-07 | 299 | 104 | 13 | MM15711 |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 6.60e-07 | 135 | 104 | 9 | M15247 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | UBA5 FBXO40 SKP2 FBXO30 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 ASB16 TRIM50 LNX1 UBE2E3 | 1.39e-06 | 343 | 104 | 13 | MM15712 |
| Pathway | REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING | 5.40e-06 | 35 | 104 | 5 | M985 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 3.14e-05 | 25 | 104 | 4 | M41829 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 6.61e-05 | 30 | 104 | 4 | M41825 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 6.61e-05 | 30 | 104 | 4 | M27762 | |
| Pathway | REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES | 6.61e-05 | 30 | 104 | 4 | MM15507 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | UBA5 FBXO40 SKP2 FBXO30 CUL5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 ASB16 NFKBIE TRIM50 SIGLEC1 LNX1 UBE2E3 | 1.10e-04 | 828 | 104 | 17 | M1058 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 1.15e-04 | 65 | 104 | 5 | MM15490 | |
| Pathway | KEGG_SPHINGOLIPID_METABOLISM | 1.89e-04 | 39 | 104 | 4 | M15955 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 2.90e-04 | 79 | 104 | 5 | M27742 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 2.94e-04 | 18 | 104 | 3 | MM15680 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 3.30e-04 | 45 | 104 | 4 | MM15508 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 3.45e-04 | 82 | 104 | 5 | M1002 | |
| Pathway | REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT | 3.47e-04 | 19 | 104 | 3 | M27020 | |
| Pathway | REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS | 4.06e-04 | 20 | 104 | 3 | M39015 | |
| Pathway | REACTOME_NEDDYLATION | 4.55e-04 | 245 | 104 | 8 | M27822 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 5.31e-04 | 90 | 104 | 5 | MM15371 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 5.42e-04 | 22 | 104 | 3 | MM15675 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 5.87e-04 | 92 | 104 | 5 | M27666 | |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 6.20e-04 | 23 | 104 | 3 | M1003 | |
| Pathway | REACTOME_TNF_SIGNALING | 7.65e-04 | 56 | 104 | 4 | MM15453 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | UBA5 FBXO40 SKP2 FBXO30 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 ASB16 TRIM50 SIGLEC1 LNX1 UBE2E3 | 7.96e-04 | 719 | 104 | 14 | MM14540 |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 7.97e-04 | 25 | 104 | 3 | MM15646 | |
| Pathway | REACTOME_TNF_SIGNALING | 8.18e-04 | 57 | 104 | 4 | M27713 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 9.32e-04 | 59 | 104 | 4 | M27763 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.02e-03 | 104 | 104 | 5 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.07e-03 | 105 | 104 | 5 | MM14842 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.26e-03 | 64 | 104 | 4 | M5650 | |
| Pathway | REACTOME_NEDDYLATION | 1.41e-03 | 226 | 104 | 7 | MM15543 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.42e-03 | 66 | 104 | 4 | MM14839 | |
| Pathway | WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES | 1.47e-03 | 8 | 104 | 2 | M45534 | |
| Pubmed | Functional interactions between ubiquitin E2 enzymes and TRIM proteins. | 1.78e-15 | 27 | 150 | 9 | 21143188 | |
| Pubmed | Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. | TRIM72 TRIM25 TRIM5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 MID1 RNF10 UBE2E3 | 2.53e-12 | 149 | 150 | 12 | 19549727 |
| Pubmed | 2.91e-11 | 7 | 150 | 5 | 34057440 | ||
| Pubmed | The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu. | 2.91e-11 | 7 | 150 | 5 | 25278022 | |
| Pubmed | 6.93e-11 | 17 | 150 | 6 | 33650289 | ||
| Pubmed | 6.93e-11 | 17 | 150 | 6 | 36563856 | ||
| Pubmed | 7.73e-11 | 8 | 150 | 5 | 28972136 | ||
| Pubmed | 7.73e-11 | 8 | 150 | 5 | 25207814 | ||
| Pubmed | 7.73e-11 | 8 | 150 | 5 | 29323787 | ||
| Pubmed | Comparison of Cross-Regulation by Different OTUB1:E2 Complexes. | 1.73e-10 | 9 | 150 | 5 | 32049508 | |
| Pubmed | 3.46e-10 | 10 | 150 | 5 | 31087003 | ||
| Pubmed | E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP. | 3.46e-10 | 10 | 150 | 5 | 21518764 | |
| Pubmed | The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway. | 5.53e-10 | 23 | 150 | 6 | 30017913 | |
| Pubmed | A dimer-monomer switch controls CHIP-dependent substrate ubiquitylation and processing. | 6.31e-10 | 11 | 150 | 5 | 36027913 | |
| Pubmed | 6.31e-10 | 11 | 150 | 5 | 19712108 | ||
| Pubmed | 7.35e-10 | 24 | 150 | 6 | 24647965 | ||
| Pubmed | E1-E2 interactions in ubiquitin and Nedd8 ligation pathways. | 1.08e-09 | 12 | 150 | 5 | 22069333 | |
| Pubmed | The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. | 1.08e-09 | 12 | 150 | 5 | 24211586 | |
| Pubmed | The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. | 1.25e-09 | 26 | 150 | 6 | 20061386 | |
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 16413270 | ||
| Pubmed | E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1). | 1.66e-09 | 5 | 150 | 4 | 15684077 | |
| Pubmed | RNF220, an E3 ubiquitin ligase that targets Sin3B for ubiquitination. | 1.66e-09 | 5 | 150 | 4 | 20170641 | |
| Pubmed | 1.75e-09 | 13 | 150 | 5 | 31120930 | ||
| Pubmed | Ubiquitination of STING at lysine 224 controls IRF3 activation. | 1.75e-09 | 13 | 150 | 5 | 28763789 | |
| Pubmed | 2.71e-09 | 14 | 150 | 5 | 36481767 | ||
| Pubmed | Ubc13-Mms2 cooperates with a family of RING E3 proteins in budding yeast membrane protein sorting. | 4.05e-09 | 15 | 150 | 5 | 32265276 | |
| Pubmed | Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114. | 4.95e-09 | 6 | 150 | 4 | 28625874 | |
| Pubmed | h-Goliath, paralog of GRAIL, is a new E3 ligase protein, expressed in human leukocytes. | 4.95e-09 | 6 | 150 | 4 | 16549277 | |
| Pubmed | The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2. | 4.95e-09 | 6 | 150 | 4 | 25701873 | |
| Pubmed | 4.95e-09 | 6 | 150 | 4 | 33962630 | ||
| Pubmed | 4.95e-09 | 6 | 150 | 4 | 30404641 | ||
| Pubmed | HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | 5.70e-09 | 90 | 150 | 8 | 35671810 | |
| Pubmed | Measuring rates of ubiquitin chain formation as a functional readout of ligase activity. | 1.15e-08 | 7 | 150 | 4 | 22350887 | |
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 24831002 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 30884854 | ||
| Pubmed | The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. | 1.15e-08 | 7 | 150 | 4 | 21685362 | |
| Pubmed | RNF122: a novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand. | 1.15e-08 | 7 | 150 | 4 | 20553626 | |
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 33282879 | ||
| Pubmed | 1.55e-08 | 19 | 150 | 5 | 27425610 | ||
| Pubmed | Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase. | 2.30e-08 | 8 | 150 | 4 | 28681414 | |
| Pubmed | Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. | 2.30e-08 | 8 | 150 | 4 | 23560854 | |
| Pubmed | 2.30e-08 | 8 | 150 | 4 | 18838541 | ||
| Pubmed | A novel route for F-box protein-mediated ubiquitination links CHIP to glycoprotein quality control. | 2.30e-08 | 8 | 150 | 4 | 16682404 | |
| Pubmed | Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. | 2.30e-08 | 8 | 150 | 4 | 15247280 | |
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 26711259 | ||
| Pubmed | Reconstitution of human CMG helicase ubiquitylation by CUL2LRR1 and multiple E2 enzymes. | 5.55e-08 | 24 | 150 | 5 | 34195792 | |
| Pubmed | 6.84e-08 | 10 | 150 | 4 | 28757353 | ||
| Pubmed | Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. | 6.92e-08 | 25 | 150 | 5 | 17597759 | |
| Pubmed | Identification of a family of closely related human ubiquitin conjugating enzymes. | 7.86e-08 | 3 | 150 | 3 | 8530467 | |
| Pubmed | 1.07e-07 | 11 | 150 | 4 | 24438103 | ||
| Pubmed | 1.60e-07 | 12 | 150 | 4 | 24905733 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.94e-07 | 95 | 150 | 7 | 29643511 | |
| Pubmed | MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. | 2.56e-07 | 32 | 150 | 5 | 20864041 | |
| Pubmed | Physical and functional interactions between ZIP kinase and UbcH5. | 3.14e-07 | 4 | 150 | 3 | 18515077 | |
| Pubmed | 3.22e-07 | 14 | 150 | 4 | 14690596 | ||
| Pubmed | 3.85e-07 | 105 | 150 | 7 | 22493164 | ||
| Pubmed | 4.37e-07 | 15 | 150 | 4 | 17452440 | ||
| Pubmed | E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. | 4.37e-07 | 15 | 150 | 4 | 21965653 | |
| Pubmed | E3-independent monoubiquitination of ubiquitin-binding proteins. | 4.37e-07 | 15 | 150 | 4 | 17588522 | |
| Pubmed | MEX is a testis-specific E3 ubiquitin ligase that promotes death receptor-induced apoptosis. | 7.81e-07 | 5 | 150 | 3 | 16522193 | |
| Pubmed | Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair. | 7.81e-07 | 5 | 150 | 3 | 26502057 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 31929179 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 25960396 | ||
| Pubmed | Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesis. | 7.81e-07 | 5 | 150 | 3 | 23509263 | |
| Pubmed | An altered-specificity ubiquitin-conjugating enzyme/ubiquitin-protein ligase pair. | 7.81e-07 | 5 | 150 | 3 | 15001359 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 11823428 | ||
| Pubmed | Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal. | 7.81e-07 | 5 | 150 | 3 | 25327252 | |
| Pubmed | The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. | 7.81e-07 | 5 | 150 | 3 | 14562029 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 23408431 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 19741096 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 8090726 | ||
| Pubmed | A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. | 8.52e-07 | 118 | 150 | 7 | 19690564 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 9990509 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 15930137 | ||
| Pubmed | Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination. | 1.56e-06 | 6 | 150 | 3 | 27678051 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 23131556 | ||
| Pubmed | The ability of TRIM3 to induce growth arrest depends on RING-dependent E3 ligase activity. | 1.56e-06 | 6 | 150 | 3 | 24393003 | |
| Pubmed | Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. | 1.56e-06 | 6 | 150 | 3 | 22124327 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 20484052 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 11274149 | ||
| Pubmed | Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. | 1.56e-06 | 6 | 150 | 3 | 15280377 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 11322894 | ||
| Pubmed | c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. | 1.88e-06 | 21 | 150 | 4 | 21113135 | |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 20051513 | ||
| Pubmed | A ubiquitin ligase complex assembles linear polyubiquitin chains. | 2.72e-06 | 7 | 150 | 3 | 17006537 | |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 22613722 | ||
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 17719635 | ||
| Pubmed | Characterisation of class VI TRIM RING domains: linking RING activity to C-terminal domain identity. | 2.72e-06 | 7 | 150 | 3 | 31028095 | |
| Pubmed | Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate. | 2.72e-06 | 7 | 150 | 3 | 20347421 | |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 16337426 | ||
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 14671314 | ||
| Pubmed | E2~Ub conjugates regulate the kinase activity of Shigella effector OspG during pathogenesis. | 4.33e-06 | 8 | 150 | 3 | 24446487 | |
| Pubmed | Involvement of Rabring7 in EGF receptor degradation as an E3 ligase. | 4.33e-06 | 8 | 150 | 3 | 17462600 | |
| Pubmed | Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. | 4.33e-06 | 8 | 150 | 3 | 14661060 | |
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 12670957 | ||
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 25172487 | ||
| Pubmed | Real-time tracking of complex ubiquitination cascades using a fluorescent confocal on-bead assay. | 5.40e-06 | 27 | 150 | 4 | 30097011 | |
| Pubmed | The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia. | 5.57e-06 | 102 | 150 | 6 | 37024974 | |
| Pubmed | Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. | 6.48e-06 | 9 | 150 | 3 | 12525502 | |
| Pubmed | E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression. | 6.48e-06 | 9 | 150 | 3 | 35114100 | |
| Interaction | ARK2C interactions | 9.82e-11 | 12 | 142 | 6 | int:ARK2C | |
| Interaction | UBTD1 interactions | 3.17e-10 | 40 | 142 | 8 | int:UBTD1 | |
| Interaction | TRIM50 interactions | 1.76e-09 | 49 | 142 | 8 | int:TRIM50 | |
| Interaction | TRIM45 interactions | 2.72e-09 | 33 | 142 | 7 | int:TRIM45 | |
| Interaction | RNF150 interactions | 3.93e-09 | 20 | 142 | 6 | int:RNF150 | |
| Interaction | UBOX5 interactions | 1.01e-08 | 23 | 142 | 6 | int:UBOX5 | |
| Interaction | MID1 interactions | STK36 MID2 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 MID1 LNX1 UBE2E3 | 1.21e-08 | 119 | 142 | 10 | int:MID1 |
| Interaction | UBE2D4 interactions | TRIM25 MID2 TRIM5 UBE2D3 UBE2D4 MID1 RNF10 RNF216 TRIM50 LNX1 | 1.21e-08 | 119 | 142 | 10 | int:UBE2D4 |
| Interaction | UBE2D3 interactions | TRIM25 MID2 TRIM58 YTHDC1 TRIM5 RNF220 UBE2D1 UBE2D2 UBE2D3 UBE2D4 MID1 RNF10 RNF216 TRIM50 | 1.35e-08 | 283 | 142 | 14 | int:UBE2D3 |
| Interaction | RNF103 interactions | 4.57e-08 | 29 | 142 | 6 | int:RNF103 | |
| Interaction | CADPS2 interactions | 5.68e-08 | 30 | 142 | 6 | int:CADPS2 | |
| Interaction | RNF122 interactions | 6.64e-08 | 16 | 142 | 5 | int:RNF122 | |
| Interaction | RNF167 interactions | 9.98e-08 | 54 | 142 | 7 | int:RNF167 | |
| Interaction | ZNRF1 interactions | 1.80e-07 | 36 | 142 | 6 | int:ZNRF1 | |
| Interaction | CHFR interactions | 2.10e-07 | 60 | 142 | 7 | int:CHFR | |
| Interaction | TOPORS interactions | 3.92e-07 | 96 | 142 | 8 | int:TOPORS | |
| Interaction | UBE2D2 interactions | UBA5 TRIM25 MID2 TRIM5 RNF220 UBE2D1 UBE2D2 UBE2D3 MID1 RNF10 RNF216 TRIM50 LNX1 | 4.14e-07 | 318 | 142 | 13 | int:UBE2D2 |
| Interaction | RNF25 interactions | 5.41e-07 | 43 | 142 | 6 | int:RNF25 | |
| Interaction | TRIM38 interactions | 9.32e-07 | 47 | 142 | 6 | int:TRIM38 | |
| Interaction | ZNRF2 interactions | 9.32e-07 | 47 | 142 | 6 | int:ZNRF2 | |
| Interaction | POLM interactions | 9.45e-07 | 26 | 142 | 5 | int:POLM | |
| Interaction | RMND5B interactions | 1.20e-06 | 49 | 142 | 6 | int:RMND5B | |
| Interaction | RNF14 interactions | 1.20e-06 | 49 | 142 | 6 | int:RNF14 | |
| Interaction | RFWD3 interactions | 1.54e-06 | 80 | 142 | 7 | int:RFWD3 | |
| Interaction | RNF216 interactions | 1.72e-06 | 52 | 142 | 6 | int:RNF216 | |
| Interaction | TRIM2 interactions | 1.92e-06 | 53 | 142 | 6 | int:TRIM2 | |
| Interaction | UBE2L3 interactions | UBA5 TRIM25 SKP2 CUL5 RNF220 UBE2D2 MID1 NCOA1 RNF216 TP53BP1 | 2.56e-06 | 211 | 142 | 10 | int:UBE2L3 |
| Interaction | RNF10 interactions | 2.71e-06 | 87 | 142 | 7 | int:RNF10 | |
| Interaction | TRIM62 interactions | 2.80e-06 | 32 | 142 | 5 | int:TRIM62 | |
| Interaction | BIRC8 interactions | 2.80e-06 | 32 | 142 | 5 | int:BIRC8 | |
| Interaction | MID2 interactions | MID2 IQCN UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 MID1 LNX1 METTL17 UBE2E3 | 3.10e-06 | 267 | 142 | 11 | int:MID2 |
| Interaction | MGRN1 interactions | 3.41e-06 | 90 | 142 | 7 | int:MGRN1 | |
| Interaction | TRIM17 interactions | 3.82e-06 | 34 | 142 | 5 | int:TRIM17 | |
| Interaction | RNF13 interactions | 4.03e-06 | 60 | 142 | 6 | int:RNF13 | |
| Interaction | DTX1 interactions | 4.43e-06 | 35 | 142 | 5 | int:DTX1 | |
| Interaction | RBCK1 interactions | 4.45e-06 | 176 | 142 | 9 | int:RBCK1 | |
| Interaction | UVSSA interactions | 5.88e-06 | 37 | 142 | 5 | int:UVSSA | |
| Interaction | CNOT4 interactions | 6.46e-06 | 65 | 142 | 6 | int:CNOT4 | |
| Interaction | MUL1 interactions | 7.36e-06 | 101 | 142 | 7 | int:MUL1 | |
| Interaction | UBE2D1 interactions | TRIM72 TRIM25 MID2 TRIM5 UBE2D1 UBE2D2 UBE2D3 MID1 RNF10 RNF216 TRIM50 | 7.76e-06 | 294 | 142 | 11 | int:UBE2D1 |
| Interaction | DTX3L interactions | 8.41e-06 | 68 | 142 | 6 | int:DTX3L | |
| Interaction | TRIM32 interactions | 9.39e-06 | 193 | 142 | 9 | int:TRIM32 | |
| Interaction | RNF220 interactions | 1.12e-05 | 42 | 142 | 5 | int:RNF220 | |
| Interaction | TRIM39 interactions | 1.15e-05 | 108 | 142 | 7 | int:TRIM39 | |
| Interaction | UFM1 interactions | 1.93e-05 | 117 | 142 | 7 | int:UFM1 | |
| Interaction | TRIM3 interactions | 2.15e-05 | 80 | 142 | 6 | int:TRIM3 | |
| Interaction | TRIM10 interactions | 2.17e-05 | 48 | 142 | 5 | int:TRIM10 | |
| Interaction | DEF8 interactions | 2.93e-05 | 51 | 142 | 5 | int:DEF8 | |
| Interaction | RNF5 interactions | 3.12e-05 | 126 | 142 | 7 | int:RNF5 | |
| Interaction | AREL1 interactions | 3.66e-05 | 27 | 142 | 4 | int:AREL1 | |
| Interaction | RNPEP interactions | 3.88e-05 | 54 | 142 | 5 | int:RNPEP | |
| Interaction | RNF114 interactions | 4.49e-05 | 91 | 142 | 6 | int:RNF114 | |
| Interaction | RNF166 interactions | 4.49e-05 | 91 | 142 | 6 | int:RNF166 | |
| Interaction | RNF34 interactions | 4.63e-05 | 56 | 142 | 5 | int:RNF34 | |
| Interaction | AMFR interactions | WIPI1 TRIM25 CYP2E1 MFSD4A GPR55 UBE2D1 UBE2D2 UBE2D3 UBE2D4 | 4.76e-05 | 237 | 142 | 9 | int:AMFR |
| Interaction | RNF126 interactions | 5.59e-05 | 138 | 142 | 7 | int:RNF126 | |
| Interaction | WSB1 interactions | 6.41e-05 | 31 | 142 | 4 | int:WSB1 | |
| Interaction | RNF111 interactions | 6.43e-05 | 97 | 142 | 6 | int:RNF111 | |
| Interaction | RNF26 interactions | 6.47e-05 | 60 | 142 | 5 | int:RNF26 | |
| Interaction | TRIM27 interactions | MID2 IQCN CUL5 UBE2D1 UBE2D2 UBE2D3 UBE2E1 BRF1 UBE2D4 NCOA1 TRIM50 LNX1 UBE2E3 | 7.24e-05 | 514 | 142 | 13 | int:TRIM27 |
| Interaction | TRIM8 interactions | 7.62e-05 | 100 | 142 | 6 | int:TRIM8 | |
| Interaction | UBA1 interactions | DENND4A TRIM25 GART UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2D4 RNPEP ARMC5 UBE2E3 | 8.15e-05 | 380 | 142 | 11 | int:UBA1 |
| Interaction | TRIM35 interactions | 8.98e-05 | 103 | 142 | 6 | int:TRIM35 | |
| Interaction | UBE2K interactions | 9.06e-05 | 149 | 142 | 7 | int:UBE2K | |
| Interaction | DTX3 interactions | 1.17e-04 | 108 | 142 | 6 | int:DTX3 | |
| Interaction | UBE4A interactions | 1.23e-04 | 109 | 142 | 6 | int:UBE4A | |
| Interaction | MKRN3 interactions | 1.24e-04 | 210 | 142 | 8 | int:MKRN3 | |
| Interaction | ZNRF4 interactions | 1.29e-04 | 110 | 142 | 6 | int:ZNRF4 | |
| Interaction | RNF185 interactions | 1.31e-04 | 158 | 142 | 7 | int:RNF185 | |
| Interaction | RNF181 interactions | 1.41e-04 | 160 | 142 | 7 | int:RNF181 | |
| Interaction | N4BP1 interactions | 1.45e-04 | 38 | 142 | 4 | int:N4BP1 | |
| Interaction | PRSS41 interactions | 1.47e-04 | 3 | 142 | 2 | int:PRSS41 | |
| Interaction | NKD2 interactions | 1.77e-04 | 40 | 142 | 4 | int:NKD2 | |
| Interaction | PSG8 interactions | 1.95e-04 | 41 | 142 | 4 | int:PSG8 | |
| Interaction | RNF11 interactions | 1.98e-04 | 169 | 142 | 7 | int:RNF11 | |
| Interaction | ANAPC11 interactions | 2.26e-04 | 78 | 142 | 5 | int:ANAPC11 | |
| Interaction | GMNN interactions | 2.28e-04 | 122 | 142 | 6 | int:GMNN | |
| Interaction | MARCHF3 interactions | 2.36e-04 | 43 | 142 | 4 | int:MARCHF3 | |
| Interaction | SHLD2 interactions | 2.36e-04 | 43 | 142 | 4 | int:SHLD2 | |
| Interaction | PJA1 interactions | 2.38e-04 | 123 | 142 | 6 | int:PJA1 | |
| Interaction | UBE2V1 interactions | 2.49e-04 | 124 | 142 | 6 | int:UBE2V1 | |
| Interaction | GPR160 interactions | 2.93e-04 | 4 | 142 | 2 | int:GPR160 | |
| Interaction | DZIP3 interactions | 3.22e-04 | 183 | 142 | 7 | int:DZIP3 | |
| Interaction | UBE2E3 interactions | 3.48e-04 | 132 | 142 | 6 | int:UBE2E3 | |
| Interaction | HERC5 interactions | 3.52e-04 | 245 | 142 | 8 | int:HERC5 | |
| Interaction | SYTL2 interactions | 3.58e-04 | 20 | 142 | 3 | int:SYTL2 | |
| Interaction | BFAR interactions | 3.61e-04 | 48 | 142 | 4 | int:BFAR | |
| Interaction | RNF115 interactions | 3.77e-04 | 134 | 142 | 6 | int:RNF115 | |
| Interaction | LRSAM1 interactions | 3.97e-04 | 88 | 142 | 5 | int:LRSAM1 | |
| Interaction | HSD17B7P2 interactions | 4.15e-04 | 21 | 142 | 3 | int:HSD17B7P2 | |
| Interaction | TNFAIP3 interactions | 4.17e-04 | 191 | 142 | 7 | int:TNFAIP3 | |
| Interaction | TRIM5 interactions | 4.63e-04 | 91 | 142 | 5 | int:TRIM5 | |
| Interaction | ATG2B interactions | 4.63e-04 | 91 | 142 | 5 | int:ATG2B | |
| Interaction | BARD1 interactions | MCM6 TRAPPC8 SKP2 UBE2D1 UBE2D2 UBE2D3 UBE2E1 UBE2E3 TP53BP1 | 4.83e-04 | 323 | 142 | 9 | int:BARD1 |
| Interaction | CRB2 interactions | 4.86e-04 | 5 | 142 | 2 | int:CRB2 | |
| Interaction | TRIM43 interactions | 5.29e-04 | 53 | 142 | 4 | int:TRIM43 | |
| Interaction | RNF125 interactions | 5.29e-04 | 53 | 142 | 4 | int:RNF125 | |
| Interaction | ATRIP interactions | 5.64e-04 | 95 | 142 | 5 | int:ATRIP | |
| Interaction | OTUB2 interactions | 5.92e-04 | 96 | 142 | 5 | int:OTUB2 | |
| Interaction | RNF168 interactions | 6.50e-04 | 98 | 142 | 5 | int:RNF168 | |
| Cytoband | 19p13.1 | 1.90e-05 | 48 | 150 | 4 | 19p13.1 | |
| GeneFamily | Ring finger proteins | TRIM72 TRIM25 MID2 TRIM58 TRIM5 RNF220 MID1 RNF10 RNF216 TRIM50 RNF180 LNX1 | 1.68e-07 | 275 | 114 | 12 | 58 |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 2.07e-07 | 41 | 114 | 6 | 102 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.30e-06 | 95 | 114 | 7 | 59 | |
| GeneFamily | Sphingosine-1-phosphate phosphatases | 3.94e-05 | 2 | 114 | 2 | 1070 | |
| GeneFamily | MCM family | 1.38e-03 | 9 | 114 | 2 | 1085 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-07 | 189 | 148 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-06 | 181 | 148 | 7 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-06 | 181 | 148 | 7 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 188 | 148 | 7 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 3.85e-06 | 193 | 148 | 7 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-06 | 194 | 148 | 7 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-06 | 195 | 148 | 7 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.04e-05 | 167 | 148 | 6 | 8ddf9da71a7c4ed53588435db826563a24cee616 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.41e-05 | 172 | 148 | 6 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 173 | 148 | 6 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-05 | 174 | 148 | 6 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-05 | 179 | 148 | 6 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.30e-05 | 182 | 148 | 6 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 183 | 148 | 6 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.41e-05 | 183 | 148 | 6 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 185 | 148 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 3.84e-05 | 187 | 148 | 6 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 188 | 148 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 188 | 148 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-05 | 188 | 148 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 188 | 148 | 6 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 148 | 6 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 189 | 148 | 6 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 190 | 148 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 190 | 148 | 6 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 190 | 148 | 6 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 4.32e-05 | 191 | 148 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 192 | 148 | 6 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 192 | 148 | 6 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-05 | 193 | 148 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | 124364adb3ded77282d449dd2cb039e6f2403a39 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.58e-05 | 193 | 148 | 6 | 984ea5b871479527ab57dd813bacae844c0d8c06 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.58e-05 | 193 | 148 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.58e-05 | 193 | 148 | 6 | 529281b912070c8655e38880ac73f5e4bd6ee4ce | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-05 | 194 | 148 | 6 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | 34b54bea013c8c724fadae357e29953c291bfce1 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | 9a5dd7ae6de72a000cf9a0d42f6b0884fa43f345 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 4.85e-05 | 195 | 148 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 4.85e-05 | 195 | 148 | 6 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Mild/Remission-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.26e-05 | 121 | 148 | 5 | 68940a552233d255b90ce5a081339c0d9d46ab02 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.28e-05 | 198 | 148 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 5.28e-05 | 198 | 148 | 6 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 198 | 148 | 6 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.28e-05 | 198 | 148 | 6 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 198 | 148 | 6 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-05 | 198 | 148 | 6 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 1.69e-04 | 155 | 148 | 5 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | COVID-19-APC-like-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.85e-04 | 158 | 148 | 5 | a0d94bd067424783863a48db20976d4c2043600c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 159 | 148 | 5 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 159 | 148 | 5 | c9e093d7c1dca83f6546adaf3d874929e2cea612 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 159 | 148 | 5 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 159 | 148 | 5 | 74655c22e9fdd88e3052b9dfb954c8fb678bd2d8 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.96e-04 | 160 | 148 | 5 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-04 | 162 | 148 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 162 | 148 | 5 | ca30d9bf61f4133566fdc91c7996e130ea554d01 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 163 | 148 | 5 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 163 | 148 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 163 | 148 | 5 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 164 | 148 | 5 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | BAL-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 2.20e-04 | 164 | 148 | 5 | 4bd9629d054545d1e3f9e5c127b5ac2388637106 | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 2.26e-04 | 165 | 148 | 5 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.26e-04 | 165 | 148 | 5 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 167 | 148 | 5 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 167 | 148 | 5 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-04 | 168 | 148 | 5 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-04 | 168 | 148 | 5 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.53e-04 | 169 | 148 | 5 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.53e-04 | 169 | 148 | 5 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 169 | 148 | 5 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.53e-04 | 169 | 148 | 5 | a4f610d07c3ba5537f4497f523669b914f7eddc1 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.67e-04 | 171 | 148 | 5 | 0d14bc9688c427ba2265984987dc3eea195b19eb | |
| ToppCell | droplet-Fat-Scat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 172 | 148 | 5 | 8a4a5ad65eec92ce4fa45c5aa01c28666307455b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-04 | 173 | 148 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 173 | 148 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 174 | 148 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 2.89e-04 | 174 | 148 | 5 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-04 | 174 | 148 | 5 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-04 | 175 | 148 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 177 | 148 | 5 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 177 | 148 | 5 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 177 | 148 | 5 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 177 | 148 | 5 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-04 | 177 | 148 | 5 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 178 | 148 | 5 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.29e-04 | 179 | 148 | 5 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-04 | 179 | 148 | 5 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Brain / Location, Cell class and cell subclass | 3.38e-04 | 180 | 148 | 5 | 51727cb66fe7a7709453f7026e0ff3d6c93d5aa5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-04 | 180 | 148 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.38e-04 | 180 | 148 | 5 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 3.55e-04 | 182 | 148 | 5 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.55e-04 | 182 | 148 | 5 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.55e-04 | 182 | 148 | 5 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-04 | 183 | 148 | 5 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 183 | 148 | 5 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-04 | 183 | 148 | 5 | 49f3ddc1c7c04b4ca837dbd6dad995add82941d6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 184 | 148 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.73e-04 | 184 | 148 | 5 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.73e-04 | 184 | 148 | 5 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 184 | 148 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 184 | 148 | 5 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| Computational | Genes in the cancer module 4. | 1.62e-05 | 21 | 81 | 4 | MODULE_4 | |
| Computational | Genes in the cancer module 82. | 2.84e-05 | 24 | 81 | 4 | MODULE_82 | |
| Computational | Ubiquitin ligases. | 1.17e-04 | 34 | 81 | 4 | MODULE_278 | |
| Computational | Neighborhood of MLL | 3.28e-04 | 174 | 81 | 7 | GCM_MLL | |
| Computational | Neighborhood of HPN | 5.06e-04 | 134 | 81 | 6 | GNF2_HPN | |
| Computational | Neighborhood of HPX | 5.27e-04 | 135 | 81 | 6 | GNF2_HPX | |
| Computational | Genes in the cancer module 233. | 5.73e-04 | 22 | 81 | 3 | MODULE_233 | |
| Disease | nuclear protein MDM1 measurement | 1.39e-04 | 4 | 143 | 2 | EFO_0802822 | |
| Disease | low density lipoprotein cholesterol measurement, body mass index | 3.45e-04 | 6 | 143 | 2 | EFO_0004340, EFO_0004611 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 3.45e-04 | 6 | 143 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | butyrylcholinesterase measurement | 3.45e-04 | 6 | 143 | 2 | EFO_0004571 | |
| Disease | glutamate measurement | 3.71e-04 | 29 | 143 | 3 | EFO_0010487 | |
| Disease | C-C motif chemokine 1 measurement | 4.82e-04 | 7 | 143 | 2 | EFO_0008041 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 8.25e-04 | 86 | 143 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 8.96e-04 | 39 | 143 | 3 | EFO_0008298 | |
| Disease | bilirubin measurement | 1.46e-03 | 442 | 143 | 8 | EFO_0004570 | |
| Disease | microphthalmia (implicated_via_orthology) | 1.49e-03 | 12 | 143 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.56e-03 | 447 | 143 | 8 | C3714756 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 1.74e-03 | 49 | 143 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | lower face morphology measurement | 1.98e-03 | 109 | 143 | 4 | EFO_0010948 | |
| Disease | superior frontal gyrus grey matter volume measurement | 2.04e-03 | 14 | 143 | 2 | EFO_0006516 | |
| Disease | Colorectal Carcinoma | SFRP2 APC2 ABCC5 FBXO30 ARHGEF10L CNPPD1 BRF1 RPAP1 PIK3R5 PHIP | 2.29e-03 | 702 | 143 | 10 | C0009402 |
| Disease | intelligence, self reported educational attainment | 2.57e-03 | 117 | 143 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.02e-03 | 17 | 143 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | triglyceride measurement, body mass index | 3.78e-03 | 19 | 143 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 3.85e-03 | 131 | 143 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 3.85e-03 | 131 | 143 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 3.85e-03 | 131 | 143 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 3.85e-03 | 131 | 143 | 4 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 4.29e-03 | 135 | 143 | 4 | C0087031 | |
| Disease | lung cancer | 4.61e-03 | 21 | 143 | 2 | MONDO_0008903 | |
| Disease | Profound Mental Retardation | 4.75e-03 | 139 | 143 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.75e-03 | 139 | 143 | 4 | C0025363 | |
| Disease | Mental deficiency | 4.75e-03 | 139 | 143 | 4 | C0917816 | |
| Disease | anorexia nervosa | 4.81e-03 | 70 | 143 | 3 | MONDO_0005351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLEKDAALALPSLCP | 211 | O14867 | |
| PILACCIPAFSSRAL | 781 | Q9HCE6 | |
| ANCIPCPLQEADTVL | 61 | Q4VNC0 | |
| ENPCLTFVTPCLLAG | 301 | Q9H4A4 | |
| FTQCDILPKPFCQLE | 101 | Q93034 | |
| EAIPLCQALSCGLPE | 2521 | Q7Z408 | |
| CLLPSAFCPAQVLLG | 596 | Q2NKJ3 | |
| IIVANEPLQPFLCKC | 3836 | Q6V0I7 | |
| LEVLLNAYPCVPSCE | 366 | Q96NS5 | |
| CLRAEILACPVSDPN | 266 | Q96SM3 | |
| VACNPACFITQLLPV | 376 | P06280 | |
| PEDRVACALTLPFIC | 651 | Q96C12 | |
| PPCELGLENETLFCL | 16 | P32238 | |
| ECVLPEPAFLCLLSA | 166 | Q9H8S5 | |
| DISRIFTCCLPGLPE | 311 | Q6ZW61 | |
| FAPVVSDLCSLPCFI | 11 | A6H8M9 | |
| ELAPIICSKCEFDPL | 171 | Q53SF7 | |
| VNALELFPQCLCLAP | 161 | Q9UHL0 | |
| SQIQEPCCSDLFLFP | 1441 | Q96BY7 | |
| LCPLALADVLSAPCP | 451 | Q7Z401 | |
| LFPDFCLPALCLQTQ | 546 | O75943 | |
| SLDPNCPRDLTDCLL | 256 | P05181 | |
| ETQFPSCDNLVLCRP | 191 | Q9H0B3 | |
| DQPRADPIPICSFCL | 206 | Q8WYB5 | |
| CLPALLECPPFQTER | 581 | Q96JH8 | |
| DCLLCFPETLPESSL | 211 | Q96K31 | |
| SINPVACLPDLAACV | 731 | O75106 | |
| FIFCDLPPLLKLSCG | 176 | Q8NGE9 | |
| LVFLACCVAPTNPRF | 296 | Q14566 | |
| FFCDIPPVLKLACTD | 191 | Q8NGN2 | |
| FCDIPAVLPLACKDT | 176 | Q8NGN7 | |
| FCDIPPLLALSCSDT | 176 | A6NL26 | |
| FIFCDLPPLLKLTCG | 176 | Q8NGQ5 | |
| DLPNPCLDLACEFLC | 4171 | Q9NZR2 | |
| CLLPSCLPAGQSVDF | 26 | Q7Z3B1 | |
| LCAACGEIQSFPLPD | 241 | Q9UJA3 | |
| SPLIADPFLSEANCL | 156 | Q8N468 | |
| FPDELPNSCLLAALS | 581 | Q8NCE2 | |
| PLLEVAVPAACACLL | 1221 | Q5IJ48 | |
| TFPNLLVACDVCLCP | 111 | P13716 | |
| APAVLLCCLALLPQE | 271 | O00221 | |
| LPENVLAPCEDFLLF | 416 | A9Z1Z3 | |
| PQALACELCGRPLSF | 46 | Q16342 | |
| FCDLPPVLALSCSDT | 181 | Q8NGJ0 | |
| LSTLCLDAACPDLPT | 161 | P40261 | |
| GLAPELLCAQLLDTC | 296 | Q8N819 | |
| CHICLQALLDPLDTP | 41 | Q8TBB1 | |
| CLEVQTRCPFILPDN | 316 | O75949 | |
| PPALLGELCAVLDSC | 21 | Q9Y616 | |
| FFCDIPPLLAISCSD | 181 | Q8NGR4 | |
| PLAACQALCTFLPLG | 396 | Q5TGP6 | |
| DPCCLQLLCTALFTP | 51 | Q9NY59 | |
| NLAVADLCLLCTLPF | 61 | Q9HC97 | |
| VQSPFPSLCTLVECL | 86 | Q9Y2T6 | |
| ECCLLPSQLLIPSLD | 716 | Q9Y2X0 | |
| CCFIPLTIPNLEQIE | 316 | Q9UJ42 | |
| LPPCNCDTLHRLLQF | 511 | O43182 | |
| CCLRPDLAILPSSDL | 661 | O15440 | |
| PEAPVEALVCNLDCL | 116 | Q8N0W3 | |
| PALPAVFLCSSRCEE | 2031 | O95996 | |
| PQCLPSLANVSSCLE | 286 | Q9BV87 | |
| CFLPENFSLPLSVDL | 241 | O43497 | |
| PNCLELRRLCFSDPL | 246 | O60609 | |
| LALAPSTCPRCLFQE | 221 | P14138 | |
| CQDCPLLAPLNDTRV | 146 | P02765 | |
| DPQGPLKDCIFDLCL | 3881 | Q9Y6R7 | |
| LLLICAPLCEPAELF | 6 | Q96LA6 | |
| PVISRCCTQDFVLPD | 396 | Q9HBI6 | |
| ATLPQCSLPELYACI | 16 | Q5TBE3 | |
| PFISRCCTQDIVLPD | 396 | Q9HCS2 | |
| CSQDDDCLPLLATPA | 511 | O95886 | |
| LLLPACCPVRAQNDT | 41 | Q8IUK8 | |
| ACPFCKSNFLPLLNI | 1521 | Q5VZ89 | |
| CLIRCNAPFPLLDAV | 41 | Q0VDD8 | |
| LLCPLEQVPCLNSEY | 56 | Q9UH90 | |
| VLQDAPACCLPLFKF | 886 | Q9Y4F3 | |
| PAVCAVALLCSLAPQ | 66 | Q96T53 | |
| DCNPLGSLPFLTCDV | 456 | A4D0S4 | |
| PAPALLCALSLALCA | 6 | P06396 | |
| LILDPCCQLPAYLST | 161 | Q96AY2 | |
| CLSFLPNTDVPILAC | 166 | Q6IA86 | |
| VLPFDDNVCLREPCE | 1371 | Q9NYQ7 | |
| DLQSEFLCPCLGLTL | 51 | P0C5K7 | |
| LLCPFERVPCLNSDF | 51 | Q8TB52 | |
| ILPPFELLCQCLCQL | 561 | Q86YV9 | |
| CFLCTALSQPPLVAV | 251 | P60507 | |
| ELPCPQLTNLACSFS | 336 | Q9H7H0 | |
| ACANVLTPDRIPEFC | 36 | Q8NCU7 | |
| APVELFLLCAALGCL | 11 | P07358 | |
| LLDAPCSLPAEAALC | 386 | Q8NAC3 | |
| FKSDCFPLPAEVCLL | 456 | Q96LW4 | |
| EALACKFLPPVEGCL | 1391 | Q3ZCN5 | |
| IFCEPCLRTLAKDNP | 451 | Q86T96 | |
| FGEVALLLPTKDPCC | 2486 | Q6ZRI0 | |
| FLCCLPSQLPNICVE | 141 | Q6NXP6 | |
| ECDRFPQDNDLCIPL | 141 | Q96HF1 | |
| DQLPNFLEELPDCPC | 301 | Q9UGT4 | |
| FLEELPDCPCTLTQA | 306 | Q9UGT4 | |
| ILPVCLPEASDDFCP | 141 | Q9NRR2 | |
| DCILEFPARNFTLPC | 311 | Q504Y2 | |
| LKLPLNEDCACAPSD | 146 | Q9NSN8 | |
| DQCISSQLDELLCPP | 906 | Q15788 | |
| ITIPLACKIFNIPCD | 386 | Q9BX95 | |
| CLGFALCASVPILPL | 376 | Q8NBI5 | |
| ELVRCPSCSFPALLD | 601 | Q9NWF9 | |
| IEEATTPCPFCKFLL | 1246 | Q8NEZ3 | |
| TPCPFCKFLLPECEL | 1251 | Q8NEZ3 | |
| AACLLDNPLCADVLF | 256 | O94844 | |
| LFDSQAPICPICQVL | 216 | Q5VTB9 | |
| LPQACQPEELLCFSC | 4106 | Q9P2P6 | |
| APLTLLCNPDFCQRI | 436 | Q9NRP7 | |
| CLDSASPLFPVCVIV | 241 | Q8IWX5 | |
| ILFPGFLCPLQDVCA | 481 | Q96M02 | |
| PALCSDGFTLVICPL | 126 | P46063 | |
| PDELLLGIFSCLCLP | 101 | Q13309 | |
| PICLELLTQPLSLDC | 16 | Q9C035 | |
| LNLCLSDLVFACLLP | 71 | P46094 | |
| ICSLLCDPNPDDPLV | 106 | P62837 | |
| FPEILDLAPFCTLKC | 716 | Q9Y5T5 | |
| PTLCCLKLAFLDPDT | 1016 | Q8WWQ0 | |
| LPAQAAPDLCSLLCL | 856 | Q8WYR1 | |
| CFACAPPLVVAANID | 226 | Q9GZZ9 | |
| CEFSICELALQPPVV | 571 | Q8N5U6 | |
| PLAEELSCSICLEPF | 6 | Q14258 | |
| ICSLLTDCNPADPLV | 166 | Q969T4 | |
| PICLELFEDPLLLPC | 11 | O15344 | |
| LFEDPLLLPCAHSLC | 16 | O15344 | |
| AKLECCPNLFSPVLI | 631 | Q5VUG0 | |
| ICSLLCDPNPDDPLV | 106 | P61077 | |
| CQPDSVALLDAVPCL | 1046 | O95359 | |
| CLLIPCIFSFPADVE | 36 | Q9BZZ2 | |
| CPASVLKCAEALQLP | 1926 | Q12888 | |
| ELSCPLCLQLFDAPV | 11 | Q6ZMU5 | |
| CSLLCNPLSCVPALE | 851 | Q9BWH6 | |
| ASVILNSPPLFCCDL | 561 | Q86X10 | |
| ELECGTQLCLLFPPD | 481 | Q96MU7 | |
| CRFGDPECQVILPLL | 291 | P22102 | |
| ARELCINAPAIDPCL | 171 | Q92994 | |
| LDCLQTFLPALSCPL | 681 | O43592 | |
| LIPDSFVPCVAALCS | 11 | Q9Y2L5 | |
| VCLDDENEFPPIILC | 421 | Q5MNZ9 | |
| RLAPCDLSLIPNSAC | 296 | A2RRH5 | |
| ICSLLCDPNPDDPLV | 106 | Q9Y2X8 | |
| SEPSCQRLDFLPLKC | 11 | Q8WV99 | |
| PICLELFEDPLLLPC | 31 | Q9UJV3 | |
| LFEDPLLLPCAHSLC | 36 | Q9UJV3 | |
| SICSLLTDCNPADPL | 151 | P51965 | |
| LDLVCKRCFDELSPP | 951 | Q5TAX3 | |
| SLPELEDRLQCPICL | 6 | Q86XT4 | |
| CPVCLDFLQEPVSVD | 16 | Q8NG06 | |
| ECDQCKELFPTPALL | 1076 | Q9NUA8 | |
| ICSLLCDPNPDDPLV | 106 | P51668 | |
| LLAQPLPDDCEILCG | 51 | Q8TCH9 | |
| DPQNCALPALTLCEK | 766 | Q9H7M6 | |
| LAIIFAPCLLRCPDN | 1846 | Q13459 |